Given the significance of skeletal muscle in whole-body insulin-induced nutrient utilisation and that impaired insulin action in skeletal underlies or worsens a number of diseases,(77) our data suggest that interventions that can improve BCAA oxidation flux, especially downstream of BCKA, hold promise for prevention/treatments of insulin resistance and its associated human chronic diseases. The gene discussed is INS; the disease is Insulin resistance.